Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)
Tumors of female reproductive system(2021)
摘要
Descripton of metastatic HER2-positive breast cancer clinical case is introduced, multilineal strategy basing on clinical situation and disease features is justified, justification of the choice of anti-HER2 treatment in every line is made, in compliance with russian and foreigh oncology associations guidelines, along with comparance of rutine treatment results and randomised trials data.
更多查看译文
关键词
breast cancer,step-by-step anti-her2 therapy,trastuzumab,pertuzumab,trastuzumab-emtansine,lapatinib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要